MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/03007995.2019.1576481

Медицинская библиотека · Current medical research and opinion · 2019

Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction.

Cosentino Eugenio Roberto, Degli Esposti Daniela, Miceli Rinaldo, Bentivenga Crescenzio, Landolfo Matteo, Fg Cicero Arrigo, Berardi Emanuela, Spinardi Luca, Magri Gianluigi, Dugato Vittorio, Borghi Claudio

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

We evaluated the clinical efficacy of sacubitril/valsartan in a group of ambulatory patients with heart failure (HF) with reduced ejection fraction (HFrEF) referred to our HF clinic.

METHODS

Patients (n = 29; 72% males; mean age 76 years) with HFrEF in New York Heart Association (NYHA) classes II-III were included in the present study. We evaluated clinical as well as echocardiographic parameters (e.g. haemodynamics, such as blood pressure and heart rate, metabolic status, echocardiographic ventricular volumes and ejection fraction [EF]), at baseline and after 6 months of treatment with sacubitril/valsartan.

RESULTS

After 6 months of sacubitril/valsartan treatment, several parameters were significantly improved. For example, EF and ventricular volumes (both diastolic and systolic) and atrial dimensions, as well as NYHA functional class (only 1 patient was still in NYHA class III) and renal impairment improved. There was no hospitalization for HF or other causes during the 6 month follow-up and no patient died.

CONCLUSIONS

Based on our real-life experience, in HFrEF patients with NYHA class II-III, the new angiotensin receptor-neprilysin inhibitor (ARNi) sacubitril/valsartan was effective in improving HF management, both from the clinical and the echocardiographic perspective.

Для цитирования: Cosentino Eugenio Roberto, Degli Esposti Daniela, Miceli Rinaldo, Bentivenga Crescenzio, Landolfo Matteo, Fg Cicero Arrigo, Berardi Emanuela, Spinardi Luca, Magri Gianluigi, Dugato Vittorio, Borghi Claudio. Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction.. Current medical research and opinion. 2019. DOI: 10.1080/03007995.2019.1576481.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.